Once the IRF-1 locus had been determined, a full-length IRF-1 cDNA probe was used to perform Southern blotting of DNA from patients with different types of leukemia and MDS associated with del(5q) to confirm IRF-1 inactivation in clinical samples. The gene discussed is IRF1; the disease is leukemia.